Clinical Trial Update: Safety and Performance of the Novalung Ultimate Kit and Xenios 2.0 During Stationary Use in Hospital and Ground-based Transport of Patients on Extracorporeal Life Support (ECLS)

View source ↗

Summary

This clinical trial update assesses the safety and performance of the Novalung Ultimate Kit and Xenios 2.0 for extracorporeal life support, in stationary hospit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardio-respiratory Failure
• Lung Injury

Snippet

Sponsor: Xenios AG | Conditions: Cardio-Respiratory Failure, Extracorporeal Membrane Oxygenation Complication | Status: NOT_YET_RECRUITING